Vivos Therapeutics share price logo

Vivos Therapeutics

NASDAQ: VVOS

$0.13

-0.00

(-0.79%)

Live

as on

Vivos Therapeutics Stock Performance

as on October 24, 2026 at 6:28 am IST

  • Day's Low

    Day's High

    $0.12
    $0.13
    downward going graph

    8.75%

    Downside

    -1.14%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.12
    $3.11
    downward going graph

    5.70%

    Downside

    2261.22%

    Upside

    downward going graph

Vivos Therapeutics share price movements today

Previous Close
$0.13
Open
$0.13
Volume
589.7K
Market Cap
$4.5M
Day's Low - High
$0.12 - $0.13
52 Week Low - High
$0.12 - $3.11

Vivos Therapeutics Historical Returns

1 Month Return
-11.01 %
3 Month Return
-66.08 %
1 Year Return
-95.54 %
3 Year Return
-98.09 %
5 Year Return
-99.86 %

Vivos Therapeutics Stock Fundamentals & Key Indicators

Check Vivos Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.5M

EPS (TTM)

-2.06

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.07

Industry PE ratio

-5.10

PEG Ratio

0.01

EBITDA

-22.7M

Revenue (TTM)

20.9M

Profit Margin

59.72%

Return On Equity TTM

2616.82%

Vivos Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vivos Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$4.5M-99.86%-0.0759.72%0.00%
Buy$121.0B-21.53%22.7566.69%3.07%
Buy$51.0B-22.73%50.8077.98%0.00%
StrongBuy$116.8B11.37%30.5965.17%1.18%
StrongBuy$173.9B-19.11%32.3456.80%2.51%

Stock Returns calculator for Vivos Therapeutics Stock including INR - Dollar returns

The Vivos Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Vivos Therapeutics investment value today

Current value as on today

₹4,789

Returns

-₹95,211

(-95.21%)

Returns from Vivos Therapeutics Stock

-₹95,572 (-95.57%)

Dollar Impact

₹361 (+0.36%)

Analyst Recommendation on Vivos Therapeutics Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Vivos Therapeutics. Average target price of $2.12

Vivos Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Vivos Therapeutics.

What analysts predicted

93.8%UPSIDE

Target Price

$2.12

Current Price

$0.1315

Analyzed by

8 Analysts

Target

$2.12

Vivos Therapeutics target price $2.12, a slight upside of 93.8% compared to current price of $0.1315. According to 8 analysts rating.

Indian Investors' Interest in Vivos Therapeutics Stock

Search interest for Vivos Therapeutics Stock has decreased by -49% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-49% versus previous 30 day period

Vivos Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Jun 2026
Total Revenue
3
3
3
4
3
3
3
6
5
5
Gross Profit
1
1
1
2
2
1
2
3
2
2
Operating Income
-3
-4
-3
-1
-2
-3
-4
-4
-6
-4
EBITDA
-1
0
-3
-1
-2
-3
-4
-5
-7
-3
Interest Expense
-
3
-
-
-
-
-
-
-
1
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-4
-3
-1
-2
-3
-5
-5
-7
-5
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-2
-4
-3
-1
-2
-3
-5
-5
-7
-5
Net Profit Margin
57.50%
55.08%
56.65%
65.39%
60.47%
50.03%
55.24%
58.04%
50.67%
57.31%

Vivos Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Mar 2022
Dec 2022
Dec 2023
Mar 2025
Mar 2026
Total Revenue
3
11
13
16
16
13
15
17
Gross Profit
2
8
10
12
10
8
9
10
Operating Income
-8
-10
-12
-19
-25
-17
-11
-19
EBITDA
-7
-9
-11
-19
-23
-12
-10
-19
Interest Expense
0
0
0
0
-
-
-
-
Depreciation
0
0
0
0
0
0
0
1
Income Before Tax
-8
-10
-12
-20
-23
-13
-11
-21
Income Tax Expense
0
-
-
-
-
-
-
-
Net Income
-8
-10
-12
-20
-23
-13
-11
-21
Net Profit Margin
71.48%
75.99%
79.69%
74.65%
62.52%
59.93%
60.00%
60.44%

Vivos Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Mar 2025
Jun 2025
Sep 2025
Mar 2026
Jun 2026
Net Income
-2
-4
-3
-1
-2
-3
-5
-5
-7
-5
Operating Cash Flow
-2
-2
-2
-3
-4
-3
-3
-4
-6
-3
Investing Cash Flow
0
0
0
0
0
0
-5
0
0
0
Financing Cash Flow
-
3
3
7
3
-
11
2
6
3
Change in Cash
-2
0
0
4
0
-3
2
-1
0
0

Vivos Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Mar 2022
Dec 2022
Dec 2023
Mar 2025
Mar 2026
Net Income
-8
-10
-15
-20
-23
-13
-11
-21
Operating Cash Flow
-5
-5
-5
-15
-19
-11
-12
-15
Investing Cash Flow
-1
0
0
-2
0
0
0
-7
Financing Cash Flow
5
4
23
24
-
10
17
18
Change in Cash
-1
0
17
5
-20
-1
4
-4

Global Institutional Holdings in Vivos Therapeutics

Check out the Institutions with significant holdings in Vivos Therapeutics.

Funds
Holdings
VANGUARD INDEX FUNDS
0.81%
Vanguard
0.18%
Fidelity Concord Street Trust
0.16%

Vivos Therapeutics News & Key Events

  • img

    Today's Timeline - 21 October

    Wed, 06:35 PM

    -

    Vivos Therapeutics regains Nasdaq compliance after boosting stockholders equity through acquisition and issuance of preferred stock.

Insights on Vivos Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -7.75M → -5.48M (in $), with an average increase of 41.4% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 3.82M → 5.15M (in $), with an average increase of 12.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Medtronic plc has given 30.5% return, outperforming this stock by 128.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp has given 17.7% return, outperforming this stock by 113.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, VVOS stock has moved down by -66.1%

About Vivos Therapeutics

Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.
OrganisationVivos Therapeutics
Headquarters7921 Southpark Plaza, Littleton, CO, 80120, US
IndustryMedical - Devices
CEOR. Kirk Huntsman

Key Management of Vivos Therapeutics

Name

Title

Mr. Michael E. Bruhn

Executive VP of Business Operations Integration

Mr. R. Kirk Huntsman

Co-Founder, Chairman of the Board & CEO

Mr. Bradford K. Amman

Principal Accounting Officer

Ms. RaeAnn Byrnes

Co-Founder and Senior VP of Events & Clinical Advisory Services

Ms. Susan McCullough

Co-Founder & Executive VP of Operations

Jennifer Hauser

Executive Assistant to CEO and Chairman & CFO

Mr. Todd Huntsman

Co-Founder & Senior VP of Product and Technology

Mr. Roman Nehemiah Franklin

Chief Financial Officer

Dr. Terry Jones

Senior VP of Human Resources

Mr. Nicholas M. DeGennaro

Senior Vice President of Mergers and Acquisition Group

FAQs

What is Vivos Therapeutics share price today?

Vivos Therapeutics share price today is $0.13 as on . Vivos Therapeutics share today touched a day high of $0.13 and a low of $0.12.

What is the 52 week high and 52 week low for Vivos Therapeutics share?

Vivos Therapeutics share touched a 52 week high of $3.11 on and a 52 week low of $0.12 on . Vivos Therapeutics stock price today i.e. is trending at $0.13,which is 95.76% down from its 52 week high and 6.05% up from its 52 week low.

What is Vivos Therapeutics's market capitalisation today?

Vivos Therapeutics market capitalisation is $0.00T as on .

How to invest in Vivos Therapeutics Stock (VVOS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Vivos Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Vivos Therapeutics Stock (VVOS) from India?

Indian investors can start investing in Vivos Therapeutics (VVOS) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Vivos Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Vivos Therapeutics share’s latest price of $0.13 as on October 24, 2026 at 12:58 am IST, you will get 76.0456 shares of Vivos Therapeutics. Learn more about fractional shares .

What are the returns that Vivos Therapeutics has given to Indian investors in the last 5 years?

Vivos Therapeutics stock has given -99.86% share price returns and 26.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?